The GlycoDomainViewer is a bioinformatic tool to aid in the mining of glycoproteomic datasets from different sources and facilitate incorporation of glycosylation into studies of protein structure and function. We present a version 2.0 of GlycoDomainViewer incorporating a number of advanced features, which enhances visibility and accessibility of the wealth of glycoproteomic data being generated. The GlycoDomainViewer enables visual exploration of glycoproteomic data, incorporating information from recent N-and O-glycoproteome studies on human and animal cell lines and some organs and body fluids. The initial data comprises sites of glycosylation for N-linked, O-GalNAc, O-Fucose, O-Xyl, O-Mannose (in both human and yeast) and cytosolic O-GlcNAc type. The data made available via this tool will be regularly updated to improve the coverage of known glycosylation sites and datasets, reflecting the advances currently being made in characterization of glycoproteomes. The tool is available at https://glycodomain.glycomics.ku.dk.
Introduction
The field of glycomics is still at its infancy with respect to availability of high-throughput methodologies and software tools compared to the genomics and proteomics fields, and the possibilities for the general biologist to analyze and integrate the glycospace-comprising the glycome (the glycan structural diversity) and glycoproteome (the glycosites on proteins)-with other Omics data is currently limited. Emerging glycan databases such as UniCarbKB (Campbell et al. 2014) and GlyTouCan (Aoki-Kinoshita et al. 2016) are improving this, but the general proteome and genome databases still only present a minor fraction of the rapidly increasing information of glycosites on proteins (Lisacek et al. 2017 ). High-throughput N-and O-glycoproteomics strategies are producing large datasets, and there is a need for integrative analysis tools to display identified glycosites in the context of individual proteins and other post-translational modifications (PTMs), enabling exploration and discovery of biological functions of glycoproteins.
A number of advances in mass spectrometry resulting from the introduction of enrichment strategies for glycopeptides and precise gene editing tools to simplify glycan structures (Zielinska et al. 2010; Steentoft et al. 2011; Halim et al. 2012 ; Thaysen-Andersen ; Levery et al. 2015; Noborn et al. 2015) have provided true Ome-wide high-throughput discovery platforms for glycans on proteins and a wealth of glycosite information. Most of this information is only available in investigator driven databases and not integrated in UniProt and other protein and gene databases, which greatly hampers access to and utilization of the data by nonexperts. There is therefore a need to collect this rapidly expanding information and overwhelming number of glycosites, makes it accessible to the community, and in particular, provide tools to help display and integrate glycosite information in general proteome analyses.
The lack of bioinformatics tools for glycomics has long been recognized as a need to be met (Packer et al. 2008; National Research Council 2012; Doherty 2015) , and there is a specific dearth of tools that support downstream data mining for glycoproteomic data. A recent description of a glycoproteomic analysis workflow illustrates how little integration exists between tools (Azevedo et al. 2017) . Originally developed for the rapidly expanding O-glycoproteome data (Steentoft et al. 2013) , the updated GlycoDomainViewer (version 2.0) now integrates all types of protein glycosylation and additional PTMs. The GlycoDomainViewer brings to the community an integrative tool for glycoproteomics that enables global analysis of the interplay between protein sequences, glycosites, types of glycosylation, and local protein fold/ domain and other PTM context. The GlycoDomainViewer integrates poly-Omics datasets and enables exploration and visualization of individual glycosites on proteins from many organisms. Here we provide a visual representation of protein context around glycosites, automatically managing the amount of information that is drawn so that data remain comprehensible. The tool aggregates and presents data produced experimentally as well as retrieved from other databases, with a view to presenting the maximum amount of relevant protein and PTM information available to explore the possible effects of glycosylation on a protein. In order to focus upon protein context, only core structures are shown, with limited glycan elaboration (i.e. T structures or the N-linked pentasaccharide core). In the following, we present the basic concept of the GlycoDomainViewer and its features, the data presented in it, and projections of how to expand the utility of the tool.
Results

Data sources
The GlycoDomainViewer (Figure 1 ) incorporates data from multiple sources, building on principles established in an earlier tool for data aggregation (Joshi et al. 2011 
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Site microheterogeneity
Glycopeptide data Glycosylation sites are shown for all major classes of glycosylation using SNFG notation NetOGlyc predictions Fig. 1 . Data visualization in the GlycoDomainViewer. The GlycoDomainViewer visually represents protein data as a set of horizontally aligned tracks. (A) Each track is dedicated to specific types of data or sources of data. This mode of display of data allows the end user to more easily distinguish patterns in the data such as PTM crosstalk, potential tissue specificity or PTM site conservation (C and D, respectively). Glycosites are indicated by the initiating sugar, or core structure present on the protein using SNFG notation. NetOGlyc predictions are shown as either a region of predicted sites (pale long rectangular shape), or individual sites (pale yellow squares). Domains (such as "EGF-like_dom") are drawn according to the scheme in Supplemental Table S2 . Where multiple types of glycan are present on the same site, this is indicated by a plus icon that can be expanded to show the individual types. SwissVar (Mottaz et al. 2010 ) single amino-acid polymorphisms are overlaid on the data, identifying polymorphisms that result in a loss of glycosylation. Alignments are grey-scale coded to match the shading in Clustal Omega. The illustration in (B) is a snapshot of a region of the FGF23 protein where important disease-causing PTM crosstalk takes place. The snapshot is zoomed in to the polypeptide GalNAc-T3-specific glycosite that participates in the regulation of the processing of FGF23 by furin (Benet-Pagès et al. 2005; Kato et al. 2006; Tagliabracci et al. 2014) . Dysregulation of the cleavage of FGF23 results in a defect in altered phosphate homeostasis. Thus, loss of GalNAc-T3 glycosylation results in increased cleavage and hyperphosphatemia, and loss of Fam20C phosphorylation results in decreased cleavage and hypophosphatemia. This regulation is complex, and arises from the interaction of three PTMs that all occur in the same local context: O-glycosylation, PC processing and phosphorylation. Interpreting the data present, we know that there are experimentally identified O-GalNAc (UniProt), phosphorylation (PhosphoSitePlus) and cleavage (TopFind) modifications occurring within the range of amino acids 179-180, and NetOGlyc4.0 predicts further sites that may be subject to glycosylation in the local area.
resources and reference publications organized by PTM is found in Table I , alongside the graphical representation for each PTM used in the viewer.
User interface
The GlycoDomainViewer user interface is accessed using a web browser on an Internet connected computer system. Minimal browser requirements are listed and updated on the home page. The elements that make up the user interface of the GlycoDomainViewer can be broken up into two categories: navigational/utility elements and data visualization. Navigational and utility elements that expose searching and secondary functionality in the viewer are presented using icon shortcuts, and are fully described in Supplemental Table SI . The data visualization in the viewer uses rows of tracks to present data. The first tracks on the viewer are reserved to illustrate the protein sequences, InterPro (Finn et al. 2017) domains and transmembrane structural elements, while a summary of PTM data appears on the second track, showing all available data. Protein domains and other structural features use a manually curated color and shape encoding scheme (Supplemental Table SII ) to ensure consistency of visualization across different proteins and organisms. The combined track can be expanded using the track pane, where after it is arranged according to cell line/tissue and additional experimental conditions.
Emerging experimental glycoproteomic data
Protein database resources do not generally integrate data from the high-throughput/shotgun methods used in the glycoproteomics and other PTM omics fields. The main reasons are requirement for validation of the PTM-site data and lack of stoichiometric quantification. However, the quality of the MS data and reproducible identifications from multiple sources warrant use of the information regardless, and all data included can be manually validated via access to spectra from appropriate experimental data repositories. Datasets from a wide variety of sources and publications have been collected and converted for use within the tool (see Table I for the available datasets), and the viewer enables tracing the provenance of data supporting each glycosite to evaluate reproducibility.
The viewer mainly provides basic glycosite identifications and highly limited information on glycan structures at these sites. For the most complex GalNAc-type O-glycosylation datasets, both Tn and T O-glycans are available due to available enrichment strategies (Steentoft et al. 2011; Khetarpal et al. 2016; King et al. 2017) . Clearly, information of glycan structures at individual glycosites is important to fully appreciate the roles glycosylation plays in fine-tuning functions of proteins. True integration of this data is still dependent on experimental methodology to be developed. It is likely that glycan repositories (such as GlyTouCan) will have a role to play in the appropriate curation of these data, while the GlycoDomainViewer can serve as the bridge between the proteomic and glycan realms.
Exploring conservation with the GlycoDomainViewer
Evolutionary conservation of protein sequences and/or position of PTMs are often useful predictors of biological importance. Conservation of specific amino acids indicates some degree of evolutionary pressure to maintain function via local site amino acid context within a protein, and simple sequence alignment tools such as Clustal Omega (Sievers et al. 2011 ) function well for this purpose. Conservation of glycosites or any other PTM is more difficult to evaluate, but for the types of PTMs with well-defined consensus sequence motifs, the conservation of the sequence motif can be predictive, and this has been extensively done with the NxS/T consensus motif for protein N-glycosylation (Zielinska et al. 2010) . However, for several types of protein glycosylation, as well as other PTMs, such well-defined sequence motifs do not exist, and assessing conservation is considerably harder. Especially for these glycosylation types (but also for N-glycosylation), it is useful to be able to visualize the local context of glycosites more generally including domain structure and overall protein sequence in regions with identified PTMs. The most illuminating example is perhaps the mucin-like domains harboring high-density GalNAc O-glycosylation, which rarely exhibts strict conservation of individual glycosites (Ser/Thr residues) but often exhibit conservation of high prevalence of Ser/Thr/Pro residues in a region, providing an indication of conservation of glycosylation and biological function. To examine conservation between local sequence contexts, a simple alignment of orthologous glycosites between organisms is usually a laborious task-protein sequences for the different orthologues need to be aligned, and then the site identifiers need to be manually adjusted for each of the sites to account for insertions and deletions in the aligned sequences. The GlycoDomainViewer automates the tasks of sequence alignment and site realignment for study of site conservation ( Figure 1D ). The tool retrieves the orthologous proteins (using Ensembl Compara (Herrero et al. 2016) ), performs an alignment on the proteins using Clustal Omega (Sievers et al. 2011 ) and then automatically adjusts site identifiers based upon the alignment. This alignment functionality is currently built into the GlycoDomainViewer via the alignment button (Supplemental Table SI ) that is enabled when more than one protein is viewed, while the automatic retrieval of orthologous proteins will be enabled in a future update.
An expanded view into the differential glycosylation of glycosites
Several types of protein O-glycosylation are differentially regulated in cells, and thus proteins may be glycosylated differently depending on the cell producing the proteins. This is because these types of glycosylation are directed by families of isoenzymes with different peptide substrate specificities, and the repertoire of these isoezymes expressed in a given cell directs the glycosylation capacity of the cell and how proteins are decorated by glycans. This is predominantly found with the GalNAc-type O-glycosylation, where up to 20 isoenzymes are involved, but other types of O-glycosylation including the O-Man type as well as C-manosylation also have the capacity for differential regulation (Buettner et al. 2013; Larsen et al. 2017) . A strategy involving differential glycoproteomics in isogenic cell lines with and without a single isoform provides information about nonredundant functions of any particular isoform , and these data will be important to include in the future to enable scientists to explore how differentially regulated glycosylation impacts protein function. These data are complex and multidimensional, and requires nontrivial processing and summarization of the data so that glycosites whose biosynthesis is linked to a specific isoform can be easily highlighted. A new feature for the viewer will be to add the results from this processing into the system alongside a corresponding track visualization methodology that will assist in the interpretation of the data.
User-defined customization of the GlycoDomainViewer
The ability to overlay user-defined tracks in genome browsers such as the UCSC Genome Browser (Kent et al. 2002) is useful, enabling the integration of local private data with publicly available data. We expect to be able to integrate custom datasets by request shortly, and in the longer term we will provide web tools so that data can be integrated independently without manual processing, which will allow for additional analysis functionality. The GlycoDomainViewer currently uses a "focused mode" when opened using a DOI link from a publication. In the focused mode, data from only the publication identified by the DOI will be shown. Allowing for custom data tracks, data can be browsed from a specific study and set of conditions, and compared with local context data uploaded in custom tracks. As an example, it would be possible to upload SNP data as a track, making it easier to identify glycosites that are affected by SNPs near other functional regions on proteins , or SNPs that introduce glycosylation sites that may affect protein function (Vogt et al. 2005) .
Data update policy
Like any database, the freshness (i.e. update frequency) of the data is of utmost importance to ensure use, validity and value of the tool. Currently most of the O-glycoproteome data being generated are from the authors research group, and this provides an opportunity for high frequency of updating in the GlycoDomainViewer. However, we have established a data update mechanism for integrated databases such that data is continually updated (with a maximum delay of 1 month) from supported reference data sources. Practically, this means that the data contained within the viewer is synchronized to the latest release of PTM data from UniProt and InterPro. Protein sequences are retrieved on demand from UniProt within the GlycoDomainViewer. New datasets that are not produced locally (i.e. new relevant "Omics publications") are added on an ad hoc basis, but are continually monitored for any mismatches in annotation due to identifiers or sequences changing as part of a quality control process.
NetOGlyc4.0 O-GalNAc glycosite prediction
The GlycoDomainViewer currently also includes predictions from the NetOGlyc4.0 predictor, enabling direct comparison of identified O-GalNAc glycosites and predictions by the algorithm. We envision including other predictors at a later stage, and have included NetOGlyc as a start because the enormous experimental data available for identified glycosites combined with the lack of a simple acceptor motif results in a need to more carefully interpret prediction results. We find that unavoidable predictions in cytosolic proteins are often misinterpreted, and the GlycoDomainViewer, with its presentation of transmembrane regions provides a visual tool to identify these erroneous predictions, and disregard them in analysis. The O-GalNAc-type prediction data are available on the tool via the inclusion of a complete prediction of the human glycoproteome by NetOGlyc4.0. The sites are rendered on the viewer as desaturated SNFG (Varki et al. 2015) symbols. The prediction data are based upon a UniProt release from 2012, however, yearly updates of predictions across different organisms are currently planned. The O-GalNAc prediction data provides additional information for many identified O-glycoproteins in terms of "missing" sequence motifs in the shotgun glycoproteomics strategy (Levery et al. 2015) . Thus, mucin-like domains are quite characteristic and most likely decorated with high density of O-glycans, but are poorly represented in the shotgun glycoproteomics datasets due to inefficient proteolysis and difficulties with MS identification and sequencing. Similarly, we rarely identify O-glycosites in the immediate juxtamembrane regions, presumably due to lack of appropriate digestion and glycopeptide fragments suitable for MS sequencing . We therefore consider the predictions additive in many O-glycoproteins, but we also appreciate that predictions of isolated sites in proteins without any identified O-glycosites should be viewed with caution.
Future perspectives
The GlycoDomainViewer is an actively developing tool, with new features and datasets being added to reflect the maturing methodologies being developed. The current data content covers basic exploratory needs, and new datasets will be added based on quality of data and demand for integration. Since the initial release of the tool in 2013 (Steentoft et al. 2013) , the latest release of GlycoDomainViewer is already greatly expanded and contains a complete set of basic features for analysis, with a number of additional features planned for release in the near future to improve and expand the utility of the tool.
A focus on providing good metadata for the collected data presented within the viewer allows for greater reuse of the data in the future, and by supplying regularized metadata, the path is eased to include the data wholesale in major proteomic or genomic databases when this is considered appropriate. UniProt has recently added the capability to view sequences in a similar manner to GlycoDomainViewer (Watkins et al. 2017) , and we hope that we can work to broaden adoption of this approach by integrating the tool with common proteome and genome databases.
Further, it is the hope to expand the data infrastructure for the GlycoDomainViewer so that it can be used to address the full complexity of the glycome. To achieve this, the GlycoDomainViewer needs to be extended with greater glycoproteomic coverage and to be modified to better support glycan structure data. It is expected that highthroughput mass spectrometry will continue to contribute the most data. Ideally, a major sequence or glycan database will take over stewardship of the information integrated into the viewer, ensuring continuity in the availability of data. One aspect of these future plans is especially challenging-the visualization of glycan hetereogeneity in protein context, highlighting microheterogeneity at specific sites. To present this complex data in a way that assists comprehension is difficult-but progress has been made with tools such as the GlycoViewer (Joshi et al. 2010) , indicating promising ways to integrate heterogeneous qualitative and quantitative glycan data in a compact presentation. However, these tools need refinement before they can provide true utility to understanding the glycome to the nonglycobiologist end user. As an open source project the GlycoDomainViewer is open to contributions of data and code from the community, and further information about ways to contribute can be found on the home page (https://glycodomain.glycomics.ku.dk/).
Supplementary data
Supplementary data is available at GLYCOBIOLOGY online.
Funding
Laege Sofus Carl Emil Friis og hustru Olga Doris Friis' Legat, The Lundbeck Foundation, The Novo Nordisk Foundation and The Danish National Research Foundation (DNRF107).
